Inherited Thrombophilia is Associated With Deep VeinThrombosis in a Colombian Population

ABSTRACT: The development of venous thromboembolism is influenced by a variety of genetic and environmental risk factors. A few studies have ascertained whether thrombophilic defects are risk factors for venous thromboembolism in Latin American populations with a variable degree of admixture, such a...

Full description

Autores:
Torres Hernández, José Domingo
Cardona Cadavid, Henry
Álvarez Pelaéz, María Leonor
Cardona Maya, Walter Darío
Castañeda Ospina, Serguei Abel
Quintero Rivera, Fabiola
Cadavid Jaramillo, Ángela Patricia
Bedoya Berrío, Gabriel de Jesús
Tobón Acosta, Luis Ignacio
Tipo de recurso:
Article of investigation
Fecha de publicación:
2006
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/26743
Acceso en línea:
http://hdl.handle.net/10495/26743
Palabra clave:
Activated Protein C Resistance
Resistencia a la Proteína C Activada
Methylenetetrahydrofolate Reductase (NADPH2)
Metilenotetrahidrofolato Reductasa (NADPH2)
Análisis Mutacional de ADN - Métodos
DNA Mutational Analysis - methods
Factor V - genética
Factor V - genetics
Protrombina - genética
Prothrombin - genetics
Frecuencia de los Genes
Gene Frequency
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Description
Summary:ABSTRACT: The development of venous thromboembolism is influenced by a variety of genetic and environmental risk factors. A few studies have ascertained whether thrombophilic defects are risk factors for venous thromboembolism in Latin American populations with a variable degree of admixture, such as the Colombian population. To address this issue, we con-ducted a case–control study involving 100 consecutive patients with deep vein thrombosisand 114 healthy controls from the Hospital Universitario San Vicente de Paúl, Medellín, Colombia. Activated protein C resistance (APC resistance) was detected in 25/99 patients vs. 6/114 controls (OR56.08, 95% CI52.23–17.47). Ten of 100 patients carried the factor V Leiden mutation vs. 1/114 controls (OR512.56, 95% CI51.61–267). APC resistance was associated with the factor V Leiden mutation in only 10/25 patients. The prothrombinG20210A mutation was found in 4/100 patients, but none of the controls (P< 0.05). There was no significant difference in the proportion of homozygous carriers of methylenetetrahydrofolate reductase C677T variant among patients and controls. In conclusion, in our studied population, factor V Leiden, APC resistance, and prothrombin G20210A were associated with an increased risk of deep vein thrombosis. However, the frequencies of these thrombophilic defects and of APC resistance associated with factor V Leiden was lower than the corresponding frequencies previously reported for Caucasian populations. Further study is required to assess the influence of ethnicity on thrombophilia.